GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Giant Biogene Holding Co Ltd (HKSE:02367) » Definitions » EV-to-FCF

Giant Biogene Holding Co (HKSE:02367) EV-to-FCF : 30.60 (As of May. 12, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Giant Biogene Holding Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Giant Biogene Holding Co's Enterprise Value is HK$47,500 Mil. Giant Biogene Holding Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,552 Mil. Therefore, Giant Biogene Holding Co's EV-to-FCF for today is 30.60.

The historical rank and industry rank for Giant Biogene Holding Co's EV-to-FCF or its related term are showing as below:

HKSE:02367' s EV-to-FCF Range Over the Past 10 Years
Min: 17.13   Med: 37.63   Max: 65.5
Current: 30.6

During the past 5 years, the highest EV-to-FCF of Giant Biogene Holding Co was 65.50. The lowest was 17.13. And the median was 37.63.

HKSE:02367's EV-to-FCF is ranked worse than
68.61% of 1150 companies
in the Consumer Packaged Goods industry
Industry Median: 18.175 vs HKSE:02367: 30.60

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-12), Giant Biogene Holding Co's stock price is HK$52.55. Giant Biogene Holding Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.619. Therefore, Giant Biogene Holding Co's PE Ratio for today is 32.46.


Giant Biogene Holding Co EV-to-FCF Historical Data

The historical data trend for Giant Biogene Holding Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Giant Biogene Holding Co EV-to-FCF Chart

Giant Biogene Holding Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
- - - 35.65 19.86

Giant Biogene Holding Co Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial - - 35.65 - 19.86

Competitive Comparison of Giant Biogene Holding Co's EV-to-FCF

For the Household & Personal Products subindustry, Giant Biogene Holding Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Giant Biogene Holding Co's EV-to-FCF Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Giant Biogene Holding Co's EV-to-FCF falls into.



Giant Biogene Holding Co EV-to-FCF Calculation

Giant Biogene Holding Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=47500.260/1552.071
=30.60

Giant Biogene Holding Co's current Enterprise Value is HK$47,500 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Giant Biogene Holding Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,552 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Giant Biogene Holding Co  (HKSE:02367) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Giant Biogene Holding Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=52.55/1.619
=32.46

Giant Biogene Holding Co's share price for today is HK$52.55.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Giant Biogene Holding Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.619.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Giant Biogene Holding Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Giant Biogene Holding Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Giant Biogene Holding Co (HKSE:02367) Business Description

Traded in Other Exchanges
N/A
Address
No. 1855, Shanglin Yuan 7th Road, Chang’an District, Shaanxi Province, Xi’an, CHN
Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.

Giant Biogene Holding Co (HKSE:02367) Headlines

No Headlines